Diseases of the respiratory system are a leading cause of morbidity, mortality and disability worldwide. Bronchiectasis is a progressive respiratory disease characterized by a permanent dilation of bronchi. The prevalence and incidence of bronchiectasis is increasing worldwide mainly due to the increased recognition of the disease and availability of better diagnostic modalities. Post-infectious bronchiectasis was the most common cause of bronchiectasis among those with identified risk factors, of which post-Tb bronchiectasis is the commonest one. The most common factors that influence prognosis and mortality are severity of disease, age, bacterial colonization, frequency of disease exacerbation and underlying and comorbid condition. Current guidelines generally recommend treatment in several categories: chest clearance and pulmonary rehabilitation techniques that aim to improve muco-ciliary clearance, muco-active drugs, anti-inflammatory therapy, bronchodilators and antibiotic treatment.